Trademark: 97635380
Word
CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA. DIVERSITY, EQUITY, AND INCLUSION
Status Date
Tuesday, March 12, 2024
Filing Date
Monday, October 17, 2022
Published for Opposition
Tuesday, January 16, 2024
41 Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
42 Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
The mark consists of a double helix to the left of the terms CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA DIVERSITY, EQUITY, AND INCLUSION.
CRISPR THERAPEUTICS DE AND I IT IS IN OUR DNA DIVERSITY EQUITY AND INCLUSION
As to "CRISPR THERAPEUTICS"
Color is not claimed as a feature of the mark.
"DE&I" AND "DIVERSITY, EQUITY, AND INCLUSION"
Mar 12, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 16, 2024
Published For Opposition
Dec 27, 2023
Notification Of Notice Of Publication E-Mailed
Dec 13, 2023
Approved For Pub - Principal Register
Dec 12, 2023
Teas/Email Correspondence Entered
Dec 11, 2023
Correspondence Received In Law Office
Dec 11, 2023
Teas Response To Office Action Received
Sep 12, 2023
Notification Of Non-Final Action E-Mailed
Sep 12, 2023
Non-Final Action E-Mailed
Sep 12, 2023
Non-Final Action Written
Jul 18, 2023
Teas/Email Correspondence Entered
Jul 18, 2023
Correspondence Received In Law Office
Jul 18, 2023
Teas Response To Office Action Received
Jun 30, 2023
Application Extension Granted/Receipt Provided
Jun 30, 2023
Application Extension To Response Period - Received
Mar 31, 2023
Notification Of Non-Final Action E-Mailed
Mar 31, 2023
Non-Final Action E-Mailed
Mar 31, 2023
Non-Final Action Written
Mar 31, 2023
Assigned To Examiner
Nov 2, 2022
Notice Of Design Search Code E-Mailed
Nov 1, 2022
New Application Office Supplied Data Entered
Oct 20, 2022
Teas Change Of Correspondence Received
Oct 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 20, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
